The c-FLIP stabilizes FoxM1 by inhibiting FoxM1 ubiquitination, thereby upregulating FoxM1 expression at the post-transcriptional level, which promotes NSCLC resistance to sulfurstrepton and osimertinib (100). This evidence concerns the gene FOXM1 and non-small cell lung carcinoma.